FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump’s 4th of July fireworks display on National Mall confirmed as largest in history

Florida man allegedly kills family’s kittens in front of teenage daughter as form of punishment: officials

Watch: WNBA Player Ejected After Nearly Taking Off Sophie Cunningham’s Head With Clothesline Maneuver

EXCLUSIVE: Teen girls recall Jersey Shore ride malfunction that left them stuck hanging upside down

Trump’s White House ballroom foes face ‘very tough argument’ at Supreme Court, legal experts say

Fauci in the congressional wringer: a test for Trump’s newly-minted Attorney General

Graham replacement hopefuls make final pitches before special election: Iran war, DSA, Flock cams and more

The Hitchhiker’s Guide to what the Senate did and didn’t do overnight

One year on, US-brokered peace between Armenia and Azerbaijan cements US foothold in the Caucasus

Joe Biden’s cancer has spread further, leaving him in ‘very painful’ condition, Hunter reveals

Florida business owners allegedly scattered 1,500 mothballs on beach to send endangered birds packing

Don Lemon Whines to Judge and Blames Trump in Bid to Get Indictment Thrown Out

Cornell bans bear butchering after students carved up creature in dorm kitchen

‘DEI queen’: Virginia Dem’s past embrace of far-left prosecutors unearthed

Slain California fire captain’s wife admits murder after Mexico capture, serving time for killing first spouse

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”